Showing results (11-20 of 101) with videos related to
Sort By:
Pageof 11
Life (Basel, Switzerland)|June 28, 2023
Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center StudyCiro Manzo, Alberto Castagna, Marco IsettaDrug Safety - Case Reports|March 5, 2017
Psychomotor Agitation Following Treatment with HydroxychloroquineCiro Manzo, Pietro Gareri, Alberto CastagnaAging Medicine (Milton (N.S.W))|April 6, 2021
COVID-19 and cardiovascular problems in elderly patients: Food for thoughtRaffaele Costa, Alberto Castagna, Giovanni RuotoloMedicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.Journal of Personalized Medicine|March 25, 2022
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future ScenariosCiro Manzo, Elvis Hysa, Alberto Castagna, et al.Medical Sciences (Basel, Switzerland)|April 23, 2025
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case ReportsCiro Manzo, Marco Isetta, Alberto Castagna, et al.Reumatologia|February 7, 2024
Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumaticaCiro Manzo, Alberto Castagna, Nicola Veronese, et al.Medicina (Kaunas, Lithuania)|April 30, 2021
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell ArteritisCiro Manzo, Maria Maslinska, Alberto Castagna, et al.Medical Hypotheses|January 10, 2021
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, et al.Medicines (Basel, Switzerland)|August 4, 2018
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with GlucocorticoidsCiro Manzo, Jordi Serra-Mestres, Alberto Castagna, et al.Pageof 11